Abstract
Introduction Genetic loci for Alzheimer's disease (AD) have been identified in whites of European ancestry, but the genetic architecture of AD among other populations is less understood. Methods We conducted a transethnic genome-wide association study (GWAS) for late-onset AD in Stage 1 sample including whites of European Ancestry, African-Americans, Japanese, and Israeli-Arabs assembled by the Alzheimer's Disease Genetics Consortium. Suggestive results from Stage 1 from novel loci were followed up using summarized results in the International Genomics Alzheimer's Project GWAS dataset. Results Genome-wide significant (GWS) associations in single-nucleotide polymorphism (SNP)–based tests (P < 5 × 10−8) were identified for SNPs in PFDN1/HBEGF, USP6NL/ECHDC3, and BZRAP1-AS1 and for the interaction of the (apolipoprotein E) APOE ε4 allele with NFIC SNP. We also obtained GWS evidence (P < 2.7 × 10−6) for gene-based association in the total sample with a novel locus, TPBG (P = 1.8 × 10−6). Discussion Our findings highlight the value of transethnic studies for identifying novel AD susceptibility loci.
Original language | English |
---|---|
Pages (from-to) | 727-738 |
Number of pages | 12 |
Journal | Alzheimer's and Dementia |
Volume | 13 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2017 |
Bibliographical note
Publisher Copyright:© 2017 The Authors
Funding
Funders | Funder number |
---|---|
National Institute of Mental Health | P50MH060451, R01MH080295 |
National Institute of Mental Health | |
National Institute on Aging | R01AG033193, P50AG005146, RC2AG036535, R01AG048927, P50AG005142, RF1AG054023, U01AG024904, U24AG021886, R01AG019085, R01AG025259, P30AG053760, U01AG016976, P01AG010491, P50AG005133, RC2AG036528, P01AG000538, P50AG005134, P50AG005131, R01AG054060, K01AG030514, P30AG013854, RF1AG051504, K23AG046377, P30AG028383, R01AG027944, P50AG016582, R01AG034504, U01AG010483, P50AG005136, P50AG025688, P50AG005138, P50AG023501, R01AG021547, P50AG005681, P50AG008671, P30AG028377, R37AG015473, R01AG026916, P01AG019724, R01AG030146, U01AG006781, P50AG016573, P50AG016574, P30AG010133, P30AG013846, R01AG030653, P50AG016570, R01AG017917, P01AG002219, P50AG005128, R01AG015819, U01AG032984, R01AG019757, R01AG026390, R01AG020688, R01AG017173, P30AG008017, R01AG031581, U24AG026395, P30AG010124, P30AG012300, P30AG010161, P01AG003991, P30AG010129, P30AG019610, P30AG008051, P50AG008702 |
National Institute on Aging | |
National Human Genome Research Institute | U01HG006375, U01HG004610 |
National Human Genome Research Institute | |
National Childhood Cancer Registry – National Cancer Institute | R01CA129769 |
National Childhood Cancer Registry – National Cancer Institute | |
National Institute of General Medical Sciences | P01GM099568 |
National Institute of General Medical Sciences | |
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | R01NS059873, P50NS039764 |
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | |
National Center for Research Resources | M01RR000096, UL1RR029893 |
National Center for Research Resources | |
National Center for Advancing Translational Sciences (NCATS) | UL1TR001445 |
National Center for Advancing Translational Sciences (NCATS) | |
Medical Research Council | G1001253, MR/K01417X/1, MR/J004758/1, G0901254 |
Medical Research Council | |
Japan Society for the Promotion of Science | 16K14649 |
Japan Society for the Promotion of Science |
Keywords
- APOE interaction
- Alzheimer's disease
- Genome-wide association
- Transethnic
ASJC Scopus subject areas
- Epidemiology
- Health Policy
- Developmental Neuroscience
- Clinical Neurology
- Geriatrics and Gerontology
- Cellular and Molecular Neuroscience
- Psychiatry and Mental health